Literature DB >> 3516298

Indications for ultrasound in the evaluation of the pathological scrotum.

R F Scott, A P Bayliss, J F Calder, W H Garvie.   

Abstract

Scrotal ultrasound scans carried out on 156 patients were reviewed in a retrospective study and the sonographic findings and indications evaluated. Ultrasound was able accurately to distinguish the normal from the pathological scrotum. Extratesticular lesions were readily differentiated from testicular lesions. Abnormal testicular echo patterns were usually associated with tumours, but orchitis, granulomas and haematomas were found to have a similar appearance. Occult testicular tumours could readily be identified. Ultrasound was also useful in excluding underlying pathology in hydroceles, in the diagnosis and follow-up of epididymitis and other epididymal lesions and in the assessment of underlying testicular damage in traumatic haematoceles. Ultrasound may also be useful in post-orchiectomy follow-up examinations to exclude tumour in the contralateral testis.

Entities:  

Mesh:

Year:  1986        PMID: 3516298     DOI: 10.1111/j.1464-410x.1986.tb09022.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  The value of scrotal ultrasound in patients with suspected testicular tumour.

Authors:  V Polák; M Hornák
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  Scrotal pain.

Authors:  R J Morgan; J R Parry
Journal:  Postgrad Med J       Date:  1987-07       Impact factor: 2.401

Review 3.  Unusual, benign asymptomatic scrotal masses in children: case reports and review of the literature.

Authors:  F Aragona; E Talenti; U Santacatterina; R Perale; G passerini Glazel
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

4.  Clinico-radiological and pathological evaluation of extra testicular scrotal lesions.

Authors:  Suparna Mukherjee; Veena Maheshwari; Roobina Khan; Syed Amjad Ali Rizvi; Kiran Alam; Syed Hasan Harris; Rajeev Sharma
Journal:  J Cytol       Date:  2013-01       Impact factor: 1.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.